News search
 |
 Research 23 Apr 2026 Job Verdonschot, Maastricht University Medical Center, and the Cardiovascular Research Institute Maastricht |
 Research 21 Apr 2026 CNIC scientists identify a biomarker that improves risk prediction in a severe form of heart failure The biomarker MR-proADM improves risk prediction in patients with transthyretin amyloid cardiomyopathy (ATTR-CM) and is associated with greater disease severity, mortality, and heart failure events. |
 Research 15 Apr 2026 Scientist at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) and the Institute for Research in Biomedicine (IRB Barcelona) uncover a key metabolic mechanism governing immune cell readiness |
 About the CNIC 31 Mar 2026 The initiative will combine innovative medical and digital technologies to improve the early detection of cardiac risk and complications in cancer patients and survivors |
 About the CNIC 30 Mar 2026 The Young Author Achievement Award recognises her research into cardiotoxicity published in JACC: Cardio-Oncology |
 |
 About the CNIC 5 Mar 2026 Justin Perry, Associate Member in the Immunology Program of the Sloan Kettering Institute at Memorial Sloan Kettering Cancer Center and an Assistant Professor in the Immunology and Microbial Pathogenesis Program at Weill Cornell Medical Center |
 Research 10 Feb 2026 The study, published in Circulation Research, identifies cardiac fibroblasts and resident macrophages as essential contributors to the characteristic electrical activity that maintains this arrhythmia |
 Research 5 Feb 2026 A prespecified landmark analysis of the REBOOT trial, published in The European Heart Journal Cardiovascular Pharmacotherapy, shows no clinical benefit of beta-blockers during the first year after infarction or beyond one year, in patients without reduced ejection fraction. |
- 1 of 29
- next ›
